These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10085879)

  • 1. Adverse drug reaction. Pemoline and dyskinesia.
    Shuster J
    Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 3. Pemoline-associated hepatic failure: a critical analysis of the literature.
    Shevell M; Schreiber R
    Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemoline in ADHD.
    Winsberg B; Barbato M
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract]   [Full Text] [Related]  

  • 5. Exacerbation of autoimmune hepatitis: another hepatotoxic effect of pemoline therapy.
    Hochman JA; Woodard SA; Cohen MB
    Pediatrics; 1998 Jan; 101(1 Pt 1):106-8. PubMed ID: 9417161
    [No Abstract]   [Full Text] [Related]  

  • 6. Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.
    Rosh JR; Dellert SF; Narkewicz M; Birnbaum A; Whitington G
    Pediatrics; 1998 May; 101(5):921-3. PubMed ID: 9565425
    [No Abstract]   [Full Text] [Related]  

  • 7. Pemoline hepatotoxicity in children.
    Marotta PJ; Roberts EA
    J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
    Heiligenstein E; Anders J
    J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of dependence on pemoline.
    Bonnet U; Davids E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemoline therapy resulting in liver transplantation.
    Adcock KG; MacElroy DE; Wolford ET; Farrington EA
    Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coming into focus. Pharmacologic treatment for ADHD.
    McDonnell MA; Moffett C
    Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surveillance method for the early identification of idiosyncratic adverse drug reactions.
    Etwel FA; Rieder MJ; Bend JR; Koren G
    Drug Saf; 2008; 31(2):169-80. PubMed ID: 18217792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
    Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
    J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic side effects of psychostimulants: a 5-year review.
    Cherland E; Fitzpatrick R
    Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between stimulant medication and tics.
    Golden GS
    Pediatr Ann; 1988 Jun; 17(6):405-6, 408. PubMed ID: 2898748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemoline-induced abnormal involuntary movements.
    Sallee FR; Stiller RL; Perel JM; Everett G
    J Clin Psychopharmacol; 1989 Apr; 9(2):125-9. PubMed ID: 2723130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 20. Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.
    Bloomingdale LM
    J Clin Psychopharmacol; 1990 Oct; 10(5):382-3. PubMed ID: 2124222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.